Quantcast

FDA says single-dose shot from J&J prevents severe COVID

Johnson & Johnson’s single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S. regulators that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.